- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00363363
Physical Activity in Fontan Patients
August 25, 2013 updated by: Brian McCrindle, The Hospital for Sick Children
Identifying Determinants and Optimizing Rehabilitation of Physical Activity for Children After the Fontan Procedure
The purpose of this study is to determine which is the most effective intervention for increasing lifestyle physical activity in Fontan patients: an education (stage of change) intervention or a physical activity (mastery experience) intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Over 100,000 Canadian children are living with congenital heart defects and approximately 1.5% of them have a univentricular heart.
The Fontan procedure allows children with functionally univentricular hearts to live relatively normal lives.
However, the cardiopulmonary physiology remains abnormal and chronic complications, including myocardial dysfunction, arrhythmias, pathway abnormalities, hepatic dysfunction, obstruction of the ventricular outflow tract or pulmonary veins, and pulmonary arteriovenous malformations may significantly reduce maximal exercise capacity and quality of life.
Quality of life and life-long heart health are, therefore, critically important for Fontan patients as their survival depends on the continued functioning of an already sub-normal cardiopulmonary physiology.
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- have undergone a successful Fontan procedure prior to 5 years of age
- 6 to 10 years of age at the start of the study
- sufficient cardiopulmonary function (based on pulmonary function tests prior to the standardized cardiorespiratory exercise test) for safe participation in moderate to vigorous physical activity
Exclusion Criteria:
- disabilities or medical conditions that may influence physical activity participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
|
Children in this arm of the study will be provided with specific activities to be completed on most days of the week.
The selected activities will be based on the child's interests and results of the baseline measures of health-related PA, MVPA and gross motor skill.
The resources and facilities available to the family and season of the year will also influence the choice of activities.
The frequency and duration of the required activities will be gradually increased until the child's baseline MVPA has been increased by a minimum of 30 minutes per day, most days of the week.
Once that increase is achieved, the activities will be modified to maintain and reinforce the higher PA level.
|
Active Comparator: 2
|
Children in this arm of the study will be provided with puzzles, stories and games to be completed each week.
The selected activities will be based on the child's interests and designed to increase the child's knowledge of activity options, perceptions of activity benefits, self-confidence for activity participation and motivation for daily activity.
The activities introduced will vary with the resources available to the family and the season of the year, and will include information about healthy eating, injury prevention, and healthy lifestyle options.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in the child's moderate-to-vigorous physical activity participation
Time Frame: From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Increase in health-related physical fitness
Time Frame: From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
Achievement of age-appropriate gross motor skills
Time Frame: From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
Change in the parents' and child's perceptions of physical activity importance, value, appropriateness and competence
Time Frame: From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
Compliance with the intervention
Time Frame: From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
From baseline to end of treatment (12 months) and follow up (6-12 months post-treatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Brian McCrindle, MD, The Hospital for Sick Children, Toronto Canada
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2006
Primary Completion (Actual)
June 1, 2008
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
August 10, 2006
First Submitted That Met QC Criteria
August 10, 2006
First Posted (Estimate)
August 15, 2006
Study Record Updates
Last Update Posted (Estimate)
August 27, 2013
Last Update Submitted That Met QC Criteria
August 25, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000008413
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Defects, Congenital
-
Oslo University HospitalUniversity of BergenCompletedHeart Septal Defects, Atrial | Heart Defects,CongenitalNorway
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
Assiut UniversityNot yet recruitingCardiac Congenital Defects
-
SeptRx, Inc.UnknownHeart Septal Defects | Heart Defects, Congenital | Foramen Ovale, PatentGermany, France
-
Medtronic Heart ValvesCompletedDysfunctional RVOT Conduits in Patients With Congenital Heart DefectsSpain, United States, Austria, Canada
-
Zhengzhou UniversityNot yet recruitingCongenital Heart DefectChina
-
Children's Hospital of Eastern OntarioHeart and Stroke Foundation of CanadaRecruitingCongenital Heart DefectCanada
-
Medical College of WisconsinNational Center for Research Resources (NCRR); Children's Hospital and Health...Terminated
-
Ain Shams UniversityCompletedHeart Defects, CongenitalEgypt
Clinical Trials on Physical Activity
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
AUSL Romagna RiminiFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingNon-Small Cell Lung CancerItaly
-
Fundación para la Investigación del Hospital Clínico...CompletedObesity | Severe Mental Disorder
-
Augusta UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Kansas... and other collaboratorsCompletedMental Disorders, SevereUnited States
-
Centre Hospitalier Departemental VendeeTerminated
-
Rio de Janeiro State UniversityCompleted
-
University of California, San DiegoRecruitingCognitive Change | Aging | Mild Cognitive Impairment | Cognitive Decline | Memory Disorders | Memory Impairment | Cognition Disorders in Old Age | Aging Problems | Memory Loss | Memory Disorders in Old Age | Memory Disorder, SpatialUnited States